glp-1 alcohol GLP‐1 Receptor Agonists for Treating Use Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical and Experimental Research glp-1 alcohol reduction receptor agonists

Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM

While NAD+ and glutathione supplements are generally well-tolerated, some individuals may experience minor side effects, such as nausea, headache, or flushing during NAD+ infusionthese typically resolve by slowing the infusion rate

Ragland August 2008 Hepatitis C *Paraenterally transmitted Contact with infected blood / blood products Blood transfusions no longer the culprit * US most likely reason, sharing of needles Sexual and perinatal transmission possible Hepatitis C WHO - 3% have chronic HCV infections In US: 3+ million become infected yearly 8000 10,000 die annually from complications Cirrhosis Liver cancer Hepatitis C Virus Positive sense, single stranded RNA Linear genome of @ 9600 nucleotides Produces viral core and envelope structures Produces non-structural / operational products Hepatitis C Virus The RNA 5 end: highly conserved un-translated /non-coding region contains genotype specific arrangements *Analysis of 5 end and the core region allows classification into one of six clades and further sub-groupings

Years away from clinical use but represents where the field is heading

Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin